Fri, Dec 19, 4:20 PM, Zacks
Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog
Merck (MRK) acquired Swiss biotech privately held company, OncoEthix, and added a promising experimental early-stage candidate, OTX015, to its oncology portfolio.
Fri, Dec 19, 3:19 PM, Zacks
Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog
Tetraphase Pharmaceuticals, Inc. announced positive top-line data from a phase III study evaluating eravacycline for the treatment of complicated intra-abdominal infection.